Scientific Advisory Board

Stephan W. Morris, M.D., is Full Member of the Departments of Pathology and Hematology-Oncology at St. Jude Children’s Research Hospital, Memphis. Previously, Dr. Morris was Associate Professor of the Department of Pediatrics at the University of Tennessee College of Medicine in Memphis. Dr. Morris has authored numerous scientific publications and is recognized as an international leader and physician scientist.

John A. Oates, M.D., is Thomas F. Frist Sr. Professor of Medicine and Professor of Pharmacology at the Vanderbilt University School of Medicine. At Vanderbilt, Dr. Oates has served as Chairman of Medicine for nearly 15 years (now Chairman Emeritus), Director of the Division of Clinical Pharmacology for 25 years, Director of the Center for Clinical Pharmacology and Drug Toxicology since 1967, and mentor to many physicians and scientists in training. Dr. Oates has a distinguished career in pharmaceutical research and academic medicine, with concentrations on internal medicine, cardiology and pharmacology. Well-funded by the National Institutes of Health, Dr. Oates’ original research and clinical contributions in the areas of hypertension, heart disease and prostaglandin biology are recognized internationally.

John A. Smith, M.D., Ph.D., MMM, is Professor of Pathology, Director of the Division of Laboratory Medicine in the Department of Pathology, and Clinical Professor in the School of Health Professions at the University of Alabama, Birmingham. A physician scientist, Dr. Smith has authored and edited many papers, patents, reviews and books. Numerous awards recognized Dr. Smith’s distinguished career in research, academic medicine and public health service.

Michael R. Waterman, Ph.D., is the Natalie Overall Warren Distinguished Professor of Biochemistry and former Chair of Biochemistry at Vanderbilt University School of Medicine. Previously, for 22 years Dr. Waterman was Professor of Biochemistry and Professor of Obstetrics & Gynecology at the University of Texas Southwestern Medical Center, Dallas. An internationally recognized scientific leader, Dr. Waterman has authored many peer reviewed articles and book chapters and received many awards throughout a career marked by 40 years of continuous grant support from the National Institutes of Health. Dr. Waterman will become Emeritus Professor of Biochemistry at Vanderbilt in October, 2012.

Alex G. Waterson, Ph.D., is Research Assistant Professor of Pharmacology and Chemistry at Vanderbilt University and Co-Principal Investigator of the Vanderbilt Chemical Diversity Center, an entry in the National Cancer Institute’s Chemical Biology Consortium. Dr. Waterson joined Vanderbilt in 2008 as Director of the Chemical Synthesis Core in the Vanderbilt Institute for Chemical Biology, and he continues to serve as a member of the Center’s operating committee. Previously, Dr. Waterson was Medicinal Chemist at GlaxoSmithKline where he received numerous awards for his contributions including 13 GSK R&D awards and an Exceptional Science Award.